Investor Presentaiton

..and Presence in Diverse Segments Therapeutic Segment-Wise YoY Segment Revenue YoY 6.8% 10.2% 8.2% 11.7% 13.9% 7.5% 8.3% 8.6% 8.6% 7.3% 44.1% 12.0% 8.8% 20.6% 18.4% 10.9% 51.0% 54.7% 58.0% 58.6% 5.2% 11.7% 6.0% 6.3% 6.7% 14.2% 9.0% 12.4% 13.8% 13.1% 9.0% 14.6% 15.4% 15.4% 14.5% 55.9% 49.0% 43.9% 45.3% 42.0% 41.4% 35.1% 31.4% 29.6% 30.8% Mar-17 Mar-18 Mar-19 Mar-20 Mar-21 Mar-17 Mar-18 Mar-19 Mar-20 Mar-21 Cardiovascular System (CVS) Central Nervous System (CNS) Gastrointestinal RX ■ OTC ■Pain management Cough and cold Anti-diabetic Others ©2021 - Marksans Pharma Limited, All Rights Reserved. 22

View entire presentation